• MIPS EC or group must participate in a COVID-19 clinical trial utilizing a drug or biological product to treat a patient with a COVID - 19 infection and report their findings through a clinical data repository or clinical data registry for the duration of the study. OR • MIPS EC or group must participate in the care of patients diagnosed.